Press releases
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
7th January 2026
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to communications@curiumpharma.com
Press releases
Press releases
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
23rd December 2025
Press releases
Curium Establishes Legal Entity in China
3rd December 2025
Press releases
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
20th November 2025
Press releases
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
17th November 2025
Press releases
Curium Announces First Commercial Doses of diagnostic radiopharmaceuticals in Czech Republic and Slovakia for Patients with Prostate Cancer
6th November 2025
Press releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
15th October 2025
Press releases
Newcastle & Oxford Set To Benefit From New Technology to Diagnose Disease
8th October 2025
Press releases
Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals
21st May 2025
Press releases
Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
12th May 2025
Press releases
Curium enhances its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis
10th April 2025
Press releases
Curium Announces Approval of Generic DTPA – Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.
2nd April 2025